IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

November 19, 2020

Dueling quantitative COVID-19 neutralizing antibody tests roll out as vaccines approach completion

As COVID-19 vaccines ready themselves for market, two companies have turned their attention to what comes next – verifying whether the vaccines provide effective and lasting protection against SARS-CoV-2.

As COVID-19 vaccines ready themselves for market, two companies have turned their attention to what comes next – verifying whether the vaccines provide effective and lasting protection against SARS-CoV-2. Imanis Life Sciences and Siemens Healthineers have both announced the development of their scalable quantitative neutralizing antibody assays, a noteworthy advancement from the +/- results yielded by widely used antibody tests.

With a quantitative test result, physicians and researchers can track neutralizing antibody titers over time to better understand the short- and long-term efficacy of COVID-19 vaccines.

Published November 19, 2020: https://www.bioworld.com/articles/500422-dueling-quantitative-covid-19-neutralizing-antibody-tests-roll-out-as-vaccines-approach-completion

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com